Top Purchase Related
Home
>
Node
>
Subnode

The shield intrauterine device

Earl, T.J.

American Family Physician 4(3): 93

1971

ISSN/ISBN: 0002-838X
PMID: 5094032
Document Number: 35714

Document emailed within 1 workday
Secure & encrypted payments

Skjeldestad, F.E. 1988: The Dalkon shield. the intrauterine device used today Tidsskrift for den Norske Laegeforening: Tidsskrift for Praktisk Medicin Ny Raekke 108(12): 960-961
Esposito, J.M.; Zarou, D.M.; Zarou, G.S. 1973: A Dalkon Shield imbedded in a myoma: case report of an unusual displacement of an intrauterine contraceptive device American Journal of Obstetrics and Gynecology 117(4): 578-581
Mumford, S.D.; Kessel, E. 1992: Was the Dalkon Shield a safe and effective intrauterine device? the conflict between case-control and clinical trial study findings Fertility and Sterility 57(6): 1151-1176
Munteanu, O.; Cirstoiu, M.; Antoniac, I.; Cirstoiu, C. 2016: Comparison of Pain Level During and After Intrauterine Device Insertion: Levonorgestrel-Releasing Intrauterine System Versus the Copper T Intrauterine Device Environmental Engineering and Management Journal 15(5): 965-972
Andolsek, L.; Teeter, R.A.; Kozuh Novak, M.; Wheeler, R.; Fortney, J.A.; Rosenberg, M.J. 1986: Time to conception after intrauterine device removal importance of duration of use intrauterine device type pelvic inflammatory disease and age International Journal of Gynecology and Obstetrics 24(3): 217-224
Brunie, A.él.; Stankevitz, K.; Nwala, A.A.; Nqumayo, M.; Chen, M.; Danna, K.; Afolabi, K.; Rademacher, K.H. 2021: Expanding long-acting contraceptive options: a prospective cohort study of the hormonal intrauterine device, copper intrauterine device, and implants in Nigeria and Zambia LANCET. Global Health 9(10): E1431-E1441
Brunie, A.él.; Stankevitz, K.; Nwala, A.A.; Nqumayo, M.; Chen, M.; Danna, K.; Afolabi, K.; Rademacher, K.H. 2021: Expanding long-acting contraceptive options: a prospective cohort study of the hormonal intrauterine device, copper intrauterine device, and implants in Nigeria and Zambia LANCET. Global Health 9(10): E1431-E1441
Brunie, A.él.; Stankevitz, K.; Nwala, A.A.; Nqumayo, M.; Chen, M.; Danna, K.; Afolabi, K.; Rademacher, K.H. 2021: Expanding long-acting contraceptive options: a prospective cohort study of the hormonal intrauterine device, copper intrauterine device, and implants in Nigeria and Zambia LANCET. Global Health 9(10): E1431-E1441
Blumenthal, P.D.; Goldthwaite, L.M. 2015: Intrauterine Device Insertion During Cesarean Delivery: the Rising Tide of the Postdelivery Intrauterine Device Obstetrics and Gynecology 126(1): 1-2
Ozgu-Erdinc, A.S.; Tasdemir, U.G.; Uygur, D.; Aktulay, A.; Tasdemir, N.; Gulerman, H.C. 2014: Outcome of intrauterine pregnancies with intrauterine device in place and effects of device location on prognosis Contraception 89(5): 426-430
Roy, S.; Azen, C. 1994: A reanalysis of the Cu-7 intrauterine contraceptive device clinical trial and the incidence of pelvic inflammatory disease: A paradigm for assessing intrauterine contraceptive device safety American Journal of Obstetrics and Gynecology 170(6): 1606
Wang, K.; Cheng, Y.; Yang, H.; Tang, Y.H.; Jiang, J.; Ji, F.; Li, L.B.; Wu, S.C. 2016: Effectiveness research of medicated γ intrauterine device and medicated genefix intrauterine device inserted immediately after abortion Zhonghua Fu Chan Ke Za Zhi 51(3): 198-203
Archer, D.F.; Desoto, K.R.; Baker, J.M. 1999: Interleukin-6 and tumor necrosis factor-α concentrations in the intrauterine cavity of postmenopausal women using an intrauterine delivery system releasing progesterone : A possible mechanism of action of the intrauterine device Contraception (Stoneham) 59(3): 175-179
Archer, D.F.; DeSoto, K.R.; Baker, J.M. 1999: Interleukin-6 and tumor necrosis factor-alpha concentrations in the intrauterine cavity of postmenopausal women using an intrauterine delivery system releasing progesterone. a possible mechanism of action of the intrauterine device Contraception 59(3): 175-179
2009: Dispositifs intra-utérins, alias stérilets : Deuxième partie : Connaître les détails pratiques de la pose d'un dispositif intra-utérin - Intrauterine contraceptive device : Part 2 : Know the practical details of the installation of an intrauterine device la Revue Prescrire 29(305): 202-206
2009: Dispositifs intra-utérins, alias stérilets : Deuxième partie : Connaître les détails pratiques de la pose d'un dispositif intra-utérin - Intrauterine contraceptive device : Part 2 : Know the practical details of the installation of an intrauterine device la Revue Prescrire 29(305): 202-206
Chadwick, J.M. 1975: The Dalkon Shield contraceptive device in general practice Medical Journal of Australia 2(14): 565-566
Badis, C.M.; Hayen, M.; el-H Nadia; Dalila, R.; Lamia, S.; Ezzeddine, S.; Hela, C.; Rim, B.A. 2000: The Dalkon Shield, a forgotten device, responsible for actinomycosis La Tunisie Medicale 78(2): 139-142
Ostergard, D.R.; Gunning, J.E. 1976: Intrauterine contraception with the copper T-200 and the Dalkon shield in nulligravid women Journal of Reproductive Medicine 17(3): 172-174
Rioux, J.E.; Cloutier, D.; Dupont, P.; Lamonde, D. 1986: Long-term study of the safety of the Dalkon Shield and Gyne-T 200 intrauterine devices Cmaj: Canadian Medical Association Journal 134(7): 747-751